CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
PARIS--(BUSINESS WIRE)--The LFB group, Biolog-id and the French Blood Transfusion Service (Etablissement Français du Sang/EFS) have announced the introduction of an RFID 1 traceability system ...
NEW DELHI, March 24, 2026 /PRNewswire/ -- According to the latest research report published by MarkNtel Advisors, the Global Plasma Fractionation Market is projected to grow at a CAGR of around 6.15% ...
- The operation aligns with Grifols' commitment to helping countries reach self-sufficiency of life-sustaining plasma-derived medicines According to Víctor Grífols Deu, co-CEO of Grifols, "This deal ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
- This transaction highlights Grifols' commitment to supporting countries such as Canada to attain self-sufficiency of essential plasma-derived medicines through collaborations with national ...
Grifols plans to upgrade its plasma fractionation plant in Clayton, NC--Courtesy of Grifols Grifols, the Spain-based specialist in blood plasma products, has opened a new plasma fractionation plant in ...
JAKARTA, June 4 (Xinhua) -- Indonesia's Health Ministry will facilitate the commercialization of the country's first plasma fractionation plant through strategic partnerships, Health Minister Budi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results